Who is sponsoring NCT05400044?

NCT05400044 is sponsored by Cairo University.

What drugs are being tested in NCT05400044?

Interventions in NCT05400044: Three dimensional maxillary bone augmentation.

What condition does NCT05400044 study?

NCT05400044 studies Atrophic Maxilla.

Is NCT05400044 still recruiting?

NCT05400044 is currently status unknown. Last updated 1 June 2022.

Last reviewed 2022-06-01 · How we verify

NCT05400044

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Bone Quality and Quantity for Three Dimensional Bone Augmentation for Maxilla Using Patient Specific Titanium Meshes Loaded With Bone Marrow Aspirate Mixed With Xenograft Versus Xenograft Mixed With Autografts Only: a Randomized Clinical Trial

Status unknown NA Last updated 1 June 2022

What this trial tests

NA trial testing Three dimensional maxillary bone augmentation in Atrophic Maxilla in 20 participants. Status unknown.

Timeline

22 February 2022

Primary endpoint
22 December 2022

31 December 2022

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	20
Start date	22 February 2022
Primary completion	22 December 2022
Estimated completion	31 December 2022
Sites	1 location across Egypt

Drugs / interventions tested

Three dimensional maxillary bone augmentation

Conditions studied

Atrophic Maxilla — all drugs for Atrophic Maxilla →

Sponsor

Cairo University

Who can join

Adults 20 to 60, any sex, with Atrophic Maxilla. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of bone quality and quantity for three dimensional bone augmentation for maxilla using titanium meshes loaded with bone marrow aspirate mixed with xenograft versus xenograft mixed with autografts only

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrophic Maxilla

Currently open trials in the same condition.

NCT06968780 — Buccal Fat Pad vs. Palatal Rotation Scarf Grafts for Soft Tissue Management Around Zygomatic Implants · NA · recruiting
NCT06737289 — SURGICAL GUIDES EFFECTIVENESS · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05400044 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 1 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05400044.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing